Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial

DSpace Repository

Show simple item record

dc.contributor.author Garbe, Claus
dc.date.accessioned 2015-10-30T10:33:11Z
dc.date.available 2015-10-30T10:33:11Z
dc.date.issued 2015
dc.identifier.issn 0732-183X
dc.identifier.uri http://hdl.handle.net/10900/66001
dc.language.iso en en
dc.publisher Amer Soc Clinical Oncology de_DE
dc.relation.uri http://dx.doi.org/10.1200/JCO.2014.56.6018
dc.rights info:eu-repo/semantics/closedAccess
dc.subject.ddc 610 de_DE
dc.title Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial de_DE
dc.type Artikel de_DE
utue.quellen.id 20150901145020_01054
utue.publikation.seiten 1191-1196 de_DE
utue.personen.roh Maio, Michele
utue.personen.roh Grob, Jean-Jacques
utue.personen.roh Aamdal, Steinar
utue.personen.roh Bondarenko, Igor
utue.personen.roh Robert, Caroline
utue.personen.roh Thomas, Luc
utue.personen.roh Garbe, Claus
utue.personen.roh Chiarion-Sileni, Vanna
utue.personen.roh Testori, Alessandro
utue.personen.roh Chen, Tai-Tsang
utue.personen.roh Tschaika, Marina
utue.personen.roh Wolchok, Jedd D.
dcterms.isPartOf.ZSTitelID Journal of Clinical Oncology de_DE
dcterms.isPartOf.ZS-Issue 10 de_DE
dcterms.isPartOf.ZS-Volume 33 de_DE
utue.fakultaet 04 Medizinische Fakultät


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record